Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
At a glance
Social responsibility
Our companies
Business Model
Development capabilites
Partnering
Pipeline
Commercial Products
News & Events
Press Releases
Awards
Publications
Conferences
News
27.04.2010
Debiopharm Group™ starts Phase I clinical trial with Debio 0932
26.04.2010
Two New Tenants for EPFL’s Innovation Square
Home
News & Events
Press Releases
PRESS RELEASES
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
18-Apr-2007
Clinical update - Debio 025 cyclophilin inhibitor for the treatment of HCV - A unique viral kinetics
31-Oct-2006
Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor for Debio-025
09-Feb-2006
Debiopharm S.A. presented results of a double-blind placebo-controlled study on first-in-class Debio-025 in HIV-1-infected subjects
06-Oct-2004
New Data presented on Debiopharm´s Debio-025 at the 11th International Symposium on Hepatits C virus and related viruses
< Prev
1
2
Next >
Results 6 - 9 of 9
Tremelimumab - codevelopment with Pfizer Inc
( 1 items )
Debio 0931
( 1 items )
Debio 0932
( 2 items )
Debio 0930
( 1 items )
Debio 0929
( 1 items )
Debio 0928
( 1 items )
Debio 0827
( 1 items )
Debio 0826
( 1 items )
Triptorelin – Trelstar® – Decapeptyl® - Pamorelin®
( 14 items )
Debio 8609 Sanvar®
( 13 items )
Debio 9902 - ZT-1
( 9 items )
Debio 0614 (istaroxime)
( 2 items )
Debio 0507
( 3 items )
Debio 0719
( 1 items )
Debio 0617
( 2 items )
Oxaliplatin – Eloxatin® – Elplat®
( 10 items )
Moapar® - Salvacyl®
( 5 items )
Other News
( 54 items )
